Canadian Guideline Homes In On Excessive Medicine Pricing
New draft guidelines outlining how Canada’s drug pricing authority will decide whether to investigate if a medicine is excessively priced are now out for consultation.
You may also be interested in...
Industry Calls For Canadian Pricing Guideline Consultation To Be Suspended
IMC, the R&D-based pharmaceutical industry association in Canada, says the guideline will “exacerbate an already unpredictable regulatory environment.”
'Status Quo' Interim Pricing Guidance Now In Force In Canada
Provisional guidance on controversial pricing reforms is now in place in Canada.
Canada Pulls Controversial Pricing Measures
Some measures aimed at reducing medicine prices in Canada have been dropped, to the relief of the pharmaceutical industry.